- Quick Answer
- How Scientists Measure Aging
- Types of Epigenetic Clocks
- The Specialized and Niche Clocks
- How Accurate Are Biological Age Tests?
- What Biological Age Tests Predict
- Can You Lower Your Score?
- Price vs. What You Actually Get
- What You're Paying For
- How Clinics Offer These Tests
- Claims Worth Questioning
- Which Test Should You Choose?
- Is Biological Age Testing Worth It?
- Bottom Line
- Frequently Asked Questions
There are now over a dozen various techniques to determine how old your body is, including DNA methylation clocks, blood biomarker calculators, gut microbiome analysis, and even a brain scan test. They don't all measure the same thing, they don't all cost the same, and they certainly aren't all equally valuable for determining what you're looking for.
This is the aspect that confuses people: biological age testing is not a single product with many price categories. It's a whole class of truly unique technologies, each trained on different data to answer a different issue. Epigenetic age tests designed to identify your birthday are not the same as those designed to forecast your mortality risk, despite the fact that both will return a single figure that seems identical on the site.
This article compares the different types of biological age tests side by side, explaining what each one predicts, what you're paying for, and which one makes sense based on your specific aim.
Quick Answer
Before the full comparison, here's the fast version, which tests which types are worth paying attention to and which are still mostly research tools
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
How Scientists Measure Aging
Before comparing value for money, it helps to see the full landscape; there are genuinely more approaches to this than most people realize.
- DNA methylation (epigenetic clocks): Track chemical modifications on the genome that shift predictably with age. Widely considered the most promising and reliable biomarker for biological age.
- Blood-biomarker tests: Use standard clinical markers (albumin, glucose, and cholesterol) to estimate phenotypic age. Tools like Aging. AI uses neural networks to process these familiar lab results.
- Telomere-length testing: Measures the protective chromosome caps that shorten as cells divide. Often criticized for high variability between individuals and weaker links to functional health than epigenetic clocks.
- Proteomic and metabolomic tests: Analyze plasma protein signatures or serum metabolites to track aging-related biological changes.
- Composite biological-age scores: Combine multiple marker types, say, DNA methylation plus clinical labs, for a broader risk picture.
- Physical-performance assessments: Grip strength, walking speed, and maximal oxygen consumption, used as functional markers of aging.
- Transcriptome-based tests: Analyze age-related gene expression (RNA-Seq) from blood or skin samples. Advanced models like the BiT age clock use binarized data to detect accelerated aging in conditions like progeria.
- Microbiome-based tests: Assess biological aging through gut, oral, or skin microbiota profiles. The Floro'clock estimates age from intestinal bacteria with accuracy comparable to some epigenetic tools.
- Imaging-based tests (brain age): Use MRI and machine learning to calculate a brain age. A brain that's biologically older than its chronological age (brain-PAD) can predict cognitive and physical disability.
- Mitotic and stem cell clocks: Tools like EpiTOC2 estimate cumulative stem cell division rather than chronological age, a genuinely useful predictor of cancer risk.
- Psychological and subjective age predictors: AI models like PsychoAge and SubjAge use behavioral and self-reported data to predict both chronological age and all-cause mortality risk.
- Skin autofluorescence (SAF): A non-invasive test measuring glycation end-product buildup in skin used to track accelerated aging in chronic kidney or cardiovascular disease.
- Frailty indices: Multidimensional measures quantifying health deficit accumulation across physical, psychological, and social function often provide a better clinical picture than chronological age alone.
- Genome instability and DNA damage tests: Specialized assessments like the micronucleus assay measure increased genomic instability with age.
|
|
Types of Epigenetic Clocks
Since DNA methylation clocks are widely considered the strongest biomarker category, it's worth understanding exactly how the generations differ; this distinction matters more than almost anything else in this comparison.
- Horvath and Hannum (first-generation): Trained primarily to predict chronological age. Accurate at guessing how old you are, but limited value for predicting actual future disease risk.
- PhenoAge and GrimAge (second-generation): Trained against biological risk and mortality instead of just time. PhenoAge uses clinical biomarkers; GrimAge adds plasma proteins and smoking history, both of which far better reflect healthspan and time-to-death.
- DunedinPACE (third-generation): A different approach entirely rather than a static age, it estimates your current pace of aging, trained on longitudinal changes in organ system integrity.
The Specialized and Niche Clocks
Beyond the generational clocks, researchers have built tools for specific tissues, life stages, and use cases worth knowing if a provider is pitching you something unusually specific.
- Tissue-specific clocks: The Horvath Skin & Blood Clock is refined for fibroblasts and skin cells, useful in progeria and rejuvenation research. MEAT measures aging specifically in skeletal muscle. The M&P cardiac-specific clock is the first built for heart tissue, sensitive to risk factors like obesity and smoking.
- Pediatric and early-life clocks: Standard adult clocks struggle with childhood development. The PedBE clock is built for pediatric cheek cells; the Wu Pediatric Clock covers ages 9–212 months; the Fetal Cell Origin signature tracks children aged 0–5.
- Mechanistic and causal clocks: EpiTOC2 estimates stem cell division rate rather than age, a strong cancer risk predictor. YingCausAge, YingDamAge, and YingAdaptAge separate CpG sites tied to biological damage from those tied to protective adaptation. NCAE-CombClock fuses machine learning with established CpG markers for a new precision standard.
- Simplified, high-throughput clocks: EpiClock uses just eight carefully selected CpG markers, keeping accuracy high while cutting sequencing cost dramatically. The Weidner clock goes even further to 3 to 5 CpG sites and still performs with impressively high accuracy.
How Accurate Are Biological Age Tests?
Accuracy isn't a single yes-or-no answer here; it depends heavily on what the test was built to predict and how it's applied.
- Accuracy and reproducibility: Most clocks correlate strongly with age, but technical variability remains real. Newer minimal-marker models like EpiClock specifically aim for higher reproducibility.
- Validation at scale: That 18,859-adult study is the clearest evidence that second- and third-generation clocks meaningfully outperform first-generation ones across a huge range of disease outcomes.
- Sample type matters: Results vary depending on whether the sample is blood, saliva, or cheek cells. Clocks are generally most reliable on the specific tissue type they were built for.
- Population and ancestry: Most clocks were developed using European or Hispanic cohorts. They show utility elsewhere, but research into East Asian populations suggests population-specific training can meaningfully improve accuracy.
- The individual-level caveat: These tests are powerful for research and population-level risk assessment. Experts are consistently clear that standalone scores aren't yet sufficiently validated for individual clinical decision-making.
What Biological Age Tests Predict
This is where the strongest evidence lives: biological age testing genuinely correlates with real health outcomes, not just abstract biology.
- Mortality: GrimAge, GrimAge v2, and PhenoAge are currently the most robust biomarkers for predicting all-cause mortality, independent of chronological age.
- Chronic disease: Accelerated biological age links significantly to type 2 diabetes, hypertension, and chronic kidney disease with especially strong predictive power for respiratory and liver conditions like COPD, lung cancer, and cirrhosis.
- Cardiovascular risk: Second-generation clocks show strong associations with cardiovascular health scores and can predict time to coronary heart disease.
- Cognitive decline: Epigenetic aging links to Alzheimer's pathology, cognitive impairment, and physical disability. Biological age also predicts stroke outcomes and recurrence better than chronological age does.
- Functional and musculoskeletal aging: Clocks connect to functional impairment, chronic low back pain, and tissue-specific aging in osteoarthritis, and accelerated biological age independently explains brain white matter changes.
- Real-time aging rate: DunedinPACE captures current multi-organ deterioration speed and shows stronger predictive value for disability than some earlier clocks.
- Acute medical crises: During the pandemic, pace of aging was actually a stronger predictor of COVID-19 severity and death than chronological age.
Worth remembering: this is statistical association at a population level, not individual diagnosis. Adding repeated measurements over time to a single baseline reading meaningfully improves how accurately these tests predict mortality risk.
Can You Lower Your Score?
If a lower biological age score is the goal, the genuinely good news is that these scores respond to real, modifiable behavior. This isn't a fixed number you're stuck with.
- Smoking cessation: The single strongest lever available. One study found quitting could lower biological age by nearly 10 years, as measured by GrimAge2.
- Nutrition: Mediterranean, plant-based, and DASH diets are all linked to slower biological aging. High vitamin D intake correlates with deceleration; high saturated fat and total calorie intake correlate with faster aging. Worth reading alongside why diet and exercise fundamentals matter.
- Alcohol: Complete abstinence shows the strongest reduction in age acceleration. Even moderate intake tends to show a slight acceleration effect.
- Weight management: Reducing BMI and abdominal fat significantly lowers age-acceleration scores, particularly on clocks sensitive to metabolic health, relevant if you're exploring proven weight-loss strategies.
- Exercise: Regular activity, especially when objectively tracked, correlates with decelerated aging, likely through better mitochondrial function and immune modulation.
- Structured interventions: Pilot trials of comprehensive 8-week diet, lifestyle, and stress-management programs have reversed epigenetic age by 3 to 4.6 years.
- Medical and social factors: Epigenetic age acceleration measurably dropped one year after kidney transplantation (not after dialysis). Higher education and strong social support also correlate with slower biological aging.
Worth being precise here: a lower score means fewer aging-related molecular changes and a better health trajectory. It doesn't mean you've 'cured' aging or achieved true rejuvenation.
Price vs. What You Actually Get
Here's where the actual comparison happens, putting the major test categories side by side against what they measure, how strong the evidence is, and roughly what they cost.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A few honest takeaways from this table: cost doesn't map cleanly onto usefulness. A cheap blood panel can be genuinely valuable for a baseline screen, while an expensive proteomic test might only make sense if you're chasing a very specific risk profile.
What You're Paying For
When you pay for a biological age test, you're not really paying for a number; you're paying for the science behind how that number was generated.
- Scientific validation: Second-generation clocks (PhenoAge, GrimAge) and third-generation clocks (DunedinPACE) carry the most rigorous empirical validation for predicting disease and mortality. Not all tests on the market meet this bar.
- Biomarker quality: Some tests use a minimal set of highly informative markers (EpiClock's 8 CpG sites) to cut cost while keeping accuracy high. Others analyze over 1,000 markers for a broader biological profile.
- Algorithm sophistication: You're essentially paying for whether the clock was trained to guess your birthday (first-generation) or to predict your actual mortality risk and physiological decline (second- and third-generation).
- Longitudinal tracking: The most clinically valuable service isn't a single reading; it's serial measurements. A trajectory over time gives far more actionable signal than one snapshot ever could.
- Physician interpretation: In a clinical setting, a result means far more when a professional contextualizes it alongside metabolic markers, body composition, and fitness data the same standard covered in executive longevity testing packages.
How Clinics Offer These Tests
Longevity clinics increasingly bundle biological age testing into a broader diagnostic suite, the same kind of structured approach covered in our guide to what longevity medicine actually involves. Worth knowing what a genuinely high-quality version of this actually looks like.
- Advanced methodology: Quality clinics use well-validated second-generation clocks (PhenoAge, GrimAge) or third-generation clocks (DunedinPACE) far more clinically relevant than first-generation clocks that only guess chronological age.
- Integrated diagnostics: A comprehensive assessment combines epigenetic data with standard clinical labs (glucose, creatinine, albumin) and functional tests (grip strength, walking speed, VO2 max).
- Personalized support: Results should translate into specific recommendations for smoking cessation, weight management, Mediterranean-style nutrition, and regular activity, given how strongly these move the needle.
- Longitudinal tracking: The most actionable data comes from repeated testing, not a single snapshot allowing clinicians to see whether interventions are genuinely working.
Claims Worth Questioning
Marketing in this space often oversimplifies genuinely complex science; a few claims are worth treating with real skepticism.
- True biological age claims: There's no universally accepted gold standard here. Every clock defines age differently based on its training data, which means you can genuinely get different scores from different tests, and that's not a flaw; it's just how the science currently works.
- Standalone diagnosis: Epigenetic clocks are powerful research tools but are still considered transitional for individual clinical decisions. A single reading should never be treated as a definitive medical diagnosis.
- Guaranteed age reversal: Small score fluctuations shouldn't be read as instant rejuvenation; technical noise, batch effects, and short-term biological variation can all move a number without anything meaningful actually changing.
- Algorithm secrecy: A reliable test should have peer-reviewed validation and a clearly explained methodology. Be wary of any provider that won't disclose their training objective or CpG site selection.
Which Test Should You Choose?
The genuinely honest answer is that best depends entirely on what you're trying to find out; there isn't one universal winner here.
- For a general health baseline: Cost-effective blood-biomarker calculators like Phenotypic Age or Aging. AI gives a solid metabolic snapshot using standard labs, though they can produce implausible results in people with conditions like advanced kidney disease.
- For serious biological-aging research: Validated second- and third-generation epigenetic clocks (GrimAge, GrimAge2, DunedinPACE) remain the standard for understanding cellular aging and forecasting mortality risk.
- For tracking whether an intervention is working: Standardized, repeated measurements with the same clock, DunedinPACE, especially for current aging pace, is what you actually need to see if lifestyle changes are working.
- For routine, affordable monitoring: High-throughput models like EpiClock deliver strong accuracy at a fraction of the sequencing cost, making repeated testing far more realistic.
Is Biological Age Testing Worth It?
Here's the honest verdict, broken into the questions that actually matter before you spend money on this.
- Is it scientifically validated? Yes, for population-level risk, though individual clinical use is still maturing. Second- and third-generation clocks carry the most rigorous validation.
- Is the result actionable? Yes. Research consistently shows biological age scores respond to smoking cessation, better nutrition, and weight management; this isn't a fixed number.
- Does a better score mean better health? Reductions in age acceleration are genuinely associated with delayed chronic disease onset and lower mortality risk.
- The real takeaway: The most expensive test isn't automatically the most useful one. Scientific validation, clinical context, and your ability to track your own trajectory over time matter far more than raw sequencing sophistication.
If you're weighing where to actually get tested, our guide to longevity clinics in Europe covers several providers offering validated biological age panels as part of a broader assessment.
Bottom Line
A biological age test is most useful when you choose it based on your goal rather than price or a single age score. Blood-biomarker tests can provide an affordable health baseline, while validated second- and third-generation epigenetic clocks such as GrimAge, PhenoAge, and DunedinPACE offer stronger evidence for disease, mortality, and aging-rate assessment. The key is to look for published validation, understand the test’s limitations, and repeat the same test over time when tracking changes. No test provides a definitive true biological age, so results are best used as one part of a broader health assessment.
Frequently Asked Questions
Which biological age test is the most accurate?
For predicting mortality and disease risk, second- and third-generation epigenetic clocks (GrimAge, PhenoAge, and DunedinPACE) currently have the strongest validation. First-generation clocks are accurate at guessing chronological age but weak at predicting actual health outcomes.
Are cheaper biological age tests worth it?
Often, yes for a general baseline. Blood-biomarker tests and high-throughput clocks like EpiClock offer solid accuracy at a much lower cost than full genome-wide sequencing, making them practical for routine monitoring.
Can different biological age tests give different results for the same person?
Yes, and that's expected, not a sign something's broken. Different clocks are trained on different objectives, one aiming to guess your age, another aiming to predict mortality so they can genuinely produce different numbers for the same person.
How much does a biological age test comparison actually cost across types?
It ranges widely, roughly from € for a standard blood-biomarker panel up to €€€ for full epigenetic or proteomic sequencing. Emerging minimal-marker clocks are narrowing that gap significantly.
What's the best biological age test for tracking progress over time?
DunedinPACE, used consistently and repeated over time, is specifically built to measure your current pace of aging, making it well-suited for tracking whether lifestyle changes are actually working.
Should I trust a test that claims to reveal my true biological age?
Be skeptical of that specific framing. There's no single gold-standard test, so any provider claiming a definitive true age without disclosing their methodology is overstating what the science can currently deliver.
Disclaimer
ExtendMy.Life is an independent longevity and aesthetic concierge service. It does not provide medical advice, diagnosis, or treatment. All medical consultations, clinical assessments, diagnostic testing, treatment recommendations, and procedures are provided exclusively by licensed healthcare professionals at independent partner clinics. ExtendMy.Life's role is to recommend suitable providers, coordinate the client journey, and simplify access to trusted clinics.
References
Mavrommatis, C., Belsky, D.W., Ying, K. et al. (2025) 'An unbiased comparison of 14 epigenetic clocks in relation to 174 incident disease outcomes', Nature Communications, 16, 11164.
Liang, R., Tang, Q., Chen, J. and Zhu, L. (2024) 'Epigenetic clocks: Beyond biological age, using the past to predict the present and future', Aging and Disease, 16(6), pp. 3520–3545.
Mavromatis, L.A., Rosoff, D.B., Bell, A.S. et al. (2023) 'Multi-omic underpinnings of epigenetic aging and human longevity', Nature Communications, 14, 2236.
Keskinov, A.A., Kraevoy, S.A. and Yudin, S.M. (2022) 'Biological age predictors: The status quo and future trends', International Journal of Molecular Sciences, 23(23), 15103.
Fitzgerald, K.N., Hodges, R., Hanes, D. et al. (2021) 'Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial', Aging, 13(7), pp. 9419–9432.
Yin, Q., Schöttker, B., Holleczek, B. et al. (2026) 'Tracking DNA methylation-based biological age over 8 years and its association with mortality in community-dwelling older adults', Clinical Epigenetics, 18, 65.
Kuo, C.-L., Chen, Z., Liu, P. et al. (2024) 'Proteomic aging clock (PAC) predicts age-related outcomes in middle-aged and older adults', Aging Cell, 23(8), e14195.
Apsley, A.T., Etzel, L., Ye, Q. and Shalev, I. (2025) 'From population science to the clinic? Limits of epigenetic clocks as personal biomarkers', Epigenomics, 17(18), pp. 1447–1461.
Ye, Q., Apsley, A.T., Etzel, L. et al. (2023) 'Telomere length and chronological age across the human lifespan: a systematic review and meta-analysis of 414 study samples including 743,019 individuals', Ageing Research Reviews, 90, 102031.